explore -WSS

explore

author：comprehensive 2025-10-01 00:30:22 - browse：9548

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： 'Revelatory' study finds a smoking impact that remains after quitting

knowledge

WSS

'Revelatory' study finds a smoking impact that remains after quitting

Private equity deals in Medicare Advantage declines

Biogen Alzheimer’s drug launch off to slow start

People with substance use disorder deserve online privacy

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Private equity deals in Medicare Advantage declines

Wikipedia

explore

focus

Anesthesiologist group: stop taking Ozempic before surgery

Private equity deals in Medicare Advantage declines

Sports medicine is finally prioritizing gender equality

People with substance use disorder deserve online privacy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

PBMs drew scrutiny in House hearing — and so did pharma

Virginia high school admissions case could be legal follow

For Medicare Advantage, Democrats want stronger protections around AI

Peter Hotez and the public health issue of online harassment

Medicare Advantage proposed rates disappoint insurers

focus

How the messy conversation about Dolly changed bioethics

People with substance use disorder deserve online privacy

Medical mystery: When a cough is not just a cough

The unintended consequences of overturning Roe v. Wade

What should King Charles tell the public about his cancer?

Akili changes sales model for its ADHD video game treatment

knowledge

leisure time

knowledge

focus